Skip to content
healthcare.dev

Olanzapine

NDC 67184-0561, Olanzapine, tablet, from Qilu Pharmaceutical Co., Ltd..

Product NDC
67184-0561
Status
Listed
Labeler
Qilu Pharmaceutical Co., Ltd.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204319
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0561 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OLANZAPINE2.5 mg/1

Pharmacologic classes

Atypical Antipsychotic [EPC]

Package NDCNDC-11Package

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6077f5c4-01d7-4c1d-97a0-cb859f98ce68

Use it

Look up 67184-0561 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0561 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67184-0561. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.